Although uncommon compared to other cancers, testicular cancer is the most common cancer in men between the ages of 15 and 35. Urology nurses are familiar with the surgical management of testicular cancer, however, they may not be familiar with the complex medical management, treatment options and lifelong follow-up required for men diagnosed with this highly curable malignancy. The information will enable the urology practitioner to better understand the health and psychosocial issues of men before, during and after treatment, including treatment options, acute and late side effects, surveillance recurrence and late effects.
Contact hours available until 10/11/2015.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation.
Faculty, Planners, and Authors Conflict of Interest Disclosure: Planning Commitee Disclosures: Lee Ann Boyd, MSN, ARNO-C, CUNP / Presenter Bureau :Warner Chilcott Leanne Schimke, MSN, CRNP-C CUNP/ Presenter :Amgen-Xgeva, Warner Chilott
There are no other disclosures to declare.
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
Accreditation Statement: Society of Urologic Nurses and Associates is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
SUNA is a provider approved by the California Board of Registered Nursing, provider number, CEP 5556.
Compare the treatment options for testicular cancer based on histolog, stage, and prognostic risk classification.
List the acute and long-term effects of radiation and chemotherapy.
Discuss the need for long-term follow up for disease surveillan.
Discuss the need for long-term follow up for disease surveillance and treatment sequelae.